Cargando…
Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates
We evaluated biofilm formation of clinical Helicobacter pylori isolates from Indonesia and its relation to antibiotic resistance. We determined the minimum inhibition concentration (MIC) of amoxicillin, clarithromycin, levofloxacin, metronidazole and tetracycline by the Etest to measure the plankton...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472329/ https://www.ncbi.nlm.nih.gov/pubmed/32722296 http://dx.doi.org/10.3390/toxins12080473 |
_version_ | 1783578963600211968 |
---|---|
author | Fauzia, Kartika Afrida Miftahussurur, Muhammad Syam, Ari Fahrial Waskito, Langgeng Agung Doohan, Dalla Rezkitha, Yudith Annisa Ayu Matsumoto, Takashi Tuan, Vo Phuoc Akada, Junko Yonezawa, Hideo Kamiya, Shigeru Yamaoka, Yoshio |
author_facet | Fauzia, Kartika Afrida Miftahussurur, Muhammad Syam, Ari Fahrial Waskito, Langgeng Agung Doohan, Dalla Rezkitha, Yudith Annisa Ayu Matsumoto, Takashi Tuan, Vo Phuoc Akada, Junko Yonezawa, Hideo Kamiya, Shigeru Yamaoka, Yoshio |
author_sort | Fauzia, Kartika Afrida |
collection | PubMed |
description | We evaluated biofilm formation of clinical Helicobacter pylori isolates from Indonesia and its relation to antibiotic resistance. We determined the minimum inhibition concentration (MIC) of amoxicillin, clarithromycin, levofloxacin, metronidazole and tetracycline by the Etest to measure the planktonic susceptibility of 101 H. pylori strains. Biofilms were quantified by the crystal violet method. The minimum biofilm eradication concentration (MBEC) was obtained by measuring the survival of bacteria in a biofilm after exposure to antibiotics. The majority of the strains formed a biofilm (93.1% (94/101)), including weak (75.5%) and strong (24.5%) biofilm-formers. Planktonic resistant and sensitive strains produced relatively equal amounts of biofilms. The resistance proportion, shown by the MBEC measurement, was higher in the strong biofilm group for all antibiotics compared to the weak biofilm group, especially for clarithromycin (p = 0.002). Several cases showed sensitivity by the MIC measurement, but resistance according to the MBEC measurements (amoxicillin, 47.6%; tetracycline, 57.1%; clarithromycin, 19.0%; levofloxacin, 38.1%; and metronidazole 38.1%). Thus, biofilm formation may increase the survival of H. pylori and its resistance to antibiotics. Biofilm-related antibiotic resistance should be evaluated with antibiotic susceptibility. |
format | Online Article Text |
id | pubmed-7472329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74723292020-09-04 Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates Fauzia, Kartika Afrida Miftahussurur, Muhammad Syam, Ari Fahrial Waskito, Langgeng Agung Doohan, Dalla Rezkitha, Yudith Annisa Ayu Matsumoto, Takashi Tuan, Vo Phuoc Akada, Junko Yonezawa, Hideo Kamiya, Shigeru Yamaoka, Yoshio Toxins (Basel) Article We evaluated biofilm formation of clinical Helicobacter pylori isolates from Indonesia and its relation to antibiotic resistance. We determined the minimum inhibition concentration (MIC) of amoxicillin, clarithromycin, levofloxacin, metronidazole and tetracycline by the Etest to measure the planktonic susceptibility of 101 H. pylori strains. Biofilms were quantified by the crystal violet method. The minimum biofilm eradication concentration (MBEC) was obtained by measuring the survival of bacteria in a biofilm after exposure to antibiotics. The majority of the strains formed a biofilm (93.1% (94/101)), including weak (75.5%) and strong (24.5%) biofilm-formers. Planktonic resistant and sensitive strains produced relatively equal amounts of biofilms. The resistance proportion, shown by the MBEC measurement, was higher in the strong biofilm group for all antibiotics compared to the weak biofilm group, especially for clarithromycin (p = 0.002). Several cases showed sensitivity by the MIC measurement, but resistance according to the MBEC measurements (amoxicillin, 47.6%; tetracycline, 57.1%; clarithromycin, 19.0%; levofloxacin, 38.1%; and metronidazole 38.1%). Thus, biofilm formation may increase the survival of H. pylori and its resistance to antibiotics. Biofilm-related antibiotic resistance should be evaluated with antibiotic susceptibility. MDPI 2020-07-24 /pmc/articles/PMC7472329/ /pubmed/32722296 http://dx.doi.org/10.3390/toxins12080473 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fauzia, Kartika Afrida Miftahussurur, Muhammad Syam, Ari Fahrial Waskito, Langgeng Agung Doohan, Dalla Rezkitha, Yudith Annisa Ayu Matsumoto, Takashi Tuan, Vo Phuoc Akada, Junko Yonezawa, Hideo Kamiya, Shigeru Yamaoka, Yoshio Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates |
title | Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates |
title_full | Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates |
title_fullStr | Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates |
title_full_unstemmed | Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates |
title_short | Biofilm Formation and Antibiotic Resistance Phenotype of Helicobacter pylori Clinical Isolates |
title_sort | biofilm formation and antibiotic resistance phenotype of helicobacter pylori clinical isolates |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472329/ https://www.ncbi.nlm.nih.gov/pubmed/32722296 http://dx.doi.org/10.3390/toxins12080473 |
work_keys_str_mv | AT fauziakartikaafrida biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT miftahussururmuhammad biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT syamarifahrial biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT waskitolanggengagung biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT doohandalla biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT rezkithayudithannisaayu biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT matsumototakashi biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT tuanvophuoc biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT akadajunko biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT yonezawahideo biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT kamiyashigeru biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates AT yamaokayoshio biofilmformationandantibioticresistancephenotypeofhelicobacterpyloriclinicalisolates |